Saturn V Capital Management as of March 31, 2023
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 18 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cymabay Therapeutics Common | 10.6 | $14M | 1.6M | 8.72 | |
| Crinetics Pharmaceuticals In Common (CRNX) | 8.9 | $12M | 741k | 16.06 | |
| Chinook Therapeutics Common | 8.8 | $12M | 507k | 23.15 | |
| Horizon Therapeutics SHS | 8.1 | $11M | 99k | 109.14 | |
| Biogen Common (BIIB) | 7.8 | $10M | 38k | 278.03 | |
| Cytokinetics Common (CYTK) | 7.4 | $10M | 283k | 35.19 | |
| Biocryst Pharmaceuticals Common (BCRX) | 7.2 | $9.7M | 1.2M | 8.34 | |
| Morphic Holding Common (MORF) | 6.9 | $9.3M | 247k | 37.64 | |
| Kalvista Pharmaceuticals Common | 6.6 | $8.8M | 1.1M | 7.86 | |
| Ascendis Pharma A/s - Sponsored ADR | 6.2 | $8.3M | 77k | 107.22 | |
| Apellis Pharmaceuticals Common | 6.1 | $8.1M | 123k | 65.96 | |
| Iteos Therapeutics Common | 4.9 | $6.5M | 481k | 13.61 | |
| Sage Therapeutics Common (SAGE) | 4.5 | $6.1M | 145k | 41.96 | |
| Amicus Therapeutics Common (FOLD) | 2.1 | $2.9M | 258k | 11.09 | |
| Arcutis Biotherapeutics Common (ARQT) | 1.5 | $2.0M | 178k | 11.00 | |
| 2seventy Bio Common | 1.3 | $1.8M | 172k | 10.20 | |
| Astria Therapeutics Common | 1.0 | $1.3M | 101k | 13.30 | |
| Scilex Holding Common | 0.1 | $85k | 10k | 8.20 |
